Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

RXi Pharmaceuticals Corp Company Profile (NASDAQ:RXII)

Consensus Ratings for RXi Pharmaceuticals Corp (NASDAQ:RXII) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.50 (652.21% upside)

Analysts' Ratings History for RXi Pharmaceuticals Corp (NASDAQ:RXII)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/22/2014HC WainrightSet Price TargetBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014LaidlawInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
5/5/2014HC WainrightInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/4/2013 forward)